Saturday - September 13, 2025
European Society of Cardiology: Beta-blockers Reduced Cardiovascular Events in Selected Heart Attack Patients Without Heart Failure in BETAMI-DANBLOCK Trials
August 30, 2025
SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release:

* * *

Beta-blockers reduced cardiovascular events in selected heart attack patients without heart failure in the BETAMI-DANBLOCK trials

* While beta-blockers are strongly recommended for patients with myocardial infarction (MI) and reduced left ventricular ejection fraction (LVEF), their role in patients with preserved or mildly reduced LVEF (40%) is l . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products